Protective effects of vitamin E and Cornus mas fruit extract on methotrexate-induced cytotoxicity in sperms of adult mice
Authors
Abstract:
This study was aimed to assess the protective effects of Cornus mas fruit extract (CMFE) and vitamin E (Vit E) on sperm quality parameters in the methotrexate (MTX)-treated mice. Forty-eight young adult male mice (8-12 weeks) were randomly divided into six groups including control and test groups. The control group received normal saline orally , and the test groups were treated MTX (20 mg kg-1, ip, once weekly), MTX + CMFE (250 mg kg-1), MTX + CMFE (500 mg kg-1), MTX + CMFE (1000 mg kg-1), and MTX + Vit E (100 IU kg-1, po) for 35 consecutive days. On day 35, after euthanasia the epididymal sperms were isolated. Then the total mean sperm count, sperm viability and motility were determined. The total antioxidant capacity (TAOC) of all experimental groups were also evaluated. The MTX-treated animals showed a significant changes in all parameters of sperm quality assessment compared to the control group. Both Vit E and CMFE were able to protect from MTX-induced effects on sperm maturity and DNA damage. Co-administration of MTX and CMFE and/or Vit E resulted in protection from MTX-reduced TAOC. In conclusion, these data suggested that MTX administration could adversely affect the sperm quality. Moreover, the protective effect of Vit E and CMFE on MTX-induced sperm toxicity was also documented.
similar resources
protective effects of vitamin e and cornus mas fruit extract on methotrexate-induced cytotoxicity in sperms of adult mice
this study was aimed to assess the protective effects of cornus mas fruit extract (cmfe) and vitamin e (vit e) on sperm quality parameters in the methotrexate (mtx)-treated mice. forty-eight young adult male mice (8-12 weeks) were randomly divided into six groups including control and test groups. the control group received normal saline orally , and the test groups were treated mtx (20 mg kg-1...
full textProtective effects of cornus mas extract on in vitro fertilization potential in methotrexate treated male mice
Current study was aimed to evaluating protective effects of cornus mas fruit extract (CMFE) in mice treated with methotrexate (MTX). For this purpose, 48 young mature male mice were divided into 6 groups. Control group received only normal saline (0.1 mLper day, intraperitoneally), and the second group was administered MTX (20 mg kg-1 perweek, intraperitoneally). The third, ...
full textProtective effects of Cornus Mas fruit extract on methotrexate-induced alterations in mice testicular tissue: Evidences for histochemical and histomorphometrical changes in an animal model study
Methotrexate (MTX) as a chemotherapeutic agent, has adverse effects on reproductive organs by enhancing oxidative stress. In this study, the protective effects of Cornus mas fruit extract (CMFE) against MTX side effects were evaluated. Forty-eight mature male NMRI mice were divided into six groups: group 1 (control) received 0.10 mL per day of normal saline intraperitoneally (IP), grou...
full textP-61: Comparing The Protective Effects of Hydro-Alcoholic Extract of Cornus Mas Versus Vitamin E on Methotrexate-Induced Damages on Sperm Parameters
Background: Methotrexate (MTX), as antimetabolite and antifolate compound, is used to treat the certain types of tissue over activity and cancers. The MTX interferes with cell division through inhibiting the purine and pyrimidine synthesis. Moreover, the toxic impact of the MTX on gonadal tissues has been reported. Therefore, current study was designed to evaluate the protective effects of corn...
full textProtective effects of cornus mas extract on in vitro fertilization potential in methotrexate treated male mice
Current study was aimed to evaluating protective effects of cornus mas fruit extract (CMFE) in mice treated with methotrexate (MTX). For this purpose, 48 young mature male mice were divided into 6 groups. Control group received only normal saline (0.1 mL per day, intraperitoneally), and the second group was administered MTX (20 mg kg(-1) per week, intraperitoneally). The third, fourth and fifth...
full textMy Resources
Journal title
volume 5 issue 1
pages 21- 27
publication date 2014-03-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023